HHV-6 Ab (Human Herpesvirus 6)
Here’s what it reflects — and what to do about it.
Longetic pulls together every lab and record you’ve had, follows how HHV-6 Ab (Human Herpesvirus 6) changes over time, and explains what’s shifting — so you walk into your next appointment prepared, with reminders for retests along the way.
What is HHV-6 Ab (Human Herpesvirus 6)?
Measures antibodies against human herpesvirus 6 (HHV-6), a common virus best known for causing roseola in young children.
This test measures IgG and/or IgM antibodies against human herpesvirus 6 (HHV-6), a widespread virus that most people are exposed to in early childhood, often causing roseola, a mild illness with fever and rash. It relates broadly to the immune system, and like other herpesviruses, HHV-6 can remain dormant in the body long-term after initial infection. Clinicians commonly order it when evaluating unexplained fever or rash in young children, or in adults with a weakened immune system when reactivation is a concern. A positive IgM generally suggests more recent infection or reactivation, while a positive IgG generally reflects past exposure, which is extremely common in the general population.
Lifestyle factors that influence this marker
- Practice regular hand hygiene, particularly around young children with active illness
- Support general immune health with balanced nutrition, adequate sleep, and regular movement
- Manage stress, since immune resilience can influence viral reactivation in some contexts
- Avoid smoking and moderate alcohol intake to support overall immune health
Tests often checked alongside this
- Complete Blood Count (CBC) — general marker of immune and inflammatory activity
- EBV VCA IgG/IgM and CMV Ab — other herpesviruses sometimes considered together when evaluating similar symptoms
How this can show up in how you look and feel
- May be associated with fever and a subsequent rash in young children, consistent with roseola
- May be associated with fatigue during active or reactivated infection
- May be associated with more significant symptoms in people with a weakened immune system
What can affect this marker
- Age, since most people are exposed to HHV-6 in early childhood
- Immune status, particularly relevant for reactivation
- Timing of exposure relative to testing
- Lab-to-lab variability in assay methods
What to track over time
- Whether IgM or IgG antibodies are present, or both
- How results relate to symptom timing, especially in young children
- Whether repeat testing is useful in the context of a weakened immune system or reactivation concerns
What to ask your doctor
- Does this result suggest recent, past, or reactivated HHV-6 infection?
- How does this relate to my or my child's current symptoms?
- Is any additional monitoring needed given my immune status?
- Could symptoms be explained by another common childhood illness?
This glossary entry is for informational purposes only and is not a substitute for professional medical advice. Read our Terms of Use.
References
About our sources
Official sources
Government health agencies, national institutes, and intergovernmental bodies whose guidelines carry regulatory or policy weight.
Clinical / professional
Medical societies, specialty colleges, and professional associations whose consensus statements reflect clinical practice standards.
Peer-reviewed research
Original research articles and systematic reviews published in indexed journals and verified through PubMed or DOI.